Health-based reference values of the Mini-Finland Health Survey: 3. Triglycerides in total serum and in different lipoprotein fractions

References

• Box G EP, Cox D R. An analysis of transformations. J R Statistic Soc B 1964; 26: 211–46
   Google Scholar
• Kannel W B., Dawber T R., Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease. Six-year follow-up experience. The Framingham Study. Ann Intern Med 1961; 55: 33–50
   PubMed Web of Science ®Google Scholar
• Tyroler H A., Heyen S, Bartel A, et al. Blood pressure and cholesterol as coronary heart disease risk factors. Arch Intern Med 1971; 28: 907–14
   Google Scholar
• Hulley S B., Roseman R H., Bawol R D., Brand R J. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383–9
   PubMed Web of Science ®Google Scholar
• Castelli W P. The triglyceride issue: A view from Framingham. Am Heart J 1986; 112: 432–7
   PubMed Web of Science ®Google Scholar
• Brunzell J D., Austin M A. Plasma triglyceride levels and coronary disease. N Engl J Med 1989; 320: 1273–5
   PubMed Web of Science ®Google Scholar
• Carlson L A., Böttiger L E. Risk factors for ischae-mic heart disease in men and women: Results of the 19-year follow-up of the Stockholm prospective study. Acta Med Scand 1985; 218: 207–11
   PubMed Web of Science ®Google Scholar
• Cambien F, Jacqueson A, Richard J L., et al. Is the level of serum triglyceride a significant predictor of coronary death in ‘normocholesterolemic’ subjects. The Paris prospective study. Am J Epidemiol 1986; 124: 624–32
   PubMed Web of Science ®Google Scholar
• Austin M A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb 1991; 11: 2–14
   PubMed Web of Science ®Google Scholar
• Havel R J., Edner H A., Bragdon H J. The distribution and chemical composition of ultracentrifug-ally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
   PubMed Web of Science ®Google Scholar
• Carlson K. Lipoprotein fractination. J Clin Path 1973; 26: 32–7
   PubMed Web of Science ®Google Scholar
• Myers L H., Phillips N R., Havel R J. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins. J Lab Clin Med 1976; 88: 491–505
   PubMed Web of Science ®Google Scholar
• Aromaa A, Heliövaara M, Impivaara O, Knekt P, Maatela J. Aims, methods and study population. Part 1. The Execution of the Mini-Finland Health Survey, A Aromaa, M Heliovaara, O Impivaara, P Knekt, J. Maatela. Publications of the Social Insurance Institution ML, Helsinki and Turku 1989; 88, In Finnish with an English summary
   Google Scholar
• Järvisalo J, Maatela J, Mäki J, Marniemi J, Reunanen A. Health-based reference values of the Mini-Finland Health Survey: 1. Serum gamma-glutamyltransferase, aspartate aminotransferase and alkaline phosphatase. Scand J Clin Lab Invest 1989; 49: 623–32
   PubMed Web of Science ®Google Scholar
• Maatela J, Marniemi J, Reunanen A, Järvisalo J, Mäki J, Tikkanen M J. Health-based reference values of the Mini-Finland Health Survey: 2. Cholesterol in total serum and in different lipoprotein fractions. Scand J Clin Lab Invest 1993; 54: 33–42
   Web of Science ®Google Scholar
• Wahlefeld A W. Triglyceride determination after enzymatic hydrolysis. Methods of enzymatic analysis, H V. Bergmeyer. Verlag Chemie and Academic Press, New York and London 1974; 1831–5
   Google Scholar
• Alström T, Gräsbeck R, Hjelm M, Skandsen S. Recommendations concerning the collection of reference values in clinical chemistry. Scand J Clin Lab Invest 1975; 35(Supp. 144)1–44
   PubMedGoogle Scholar
• Solberg H E., International Federation of Clinical Chemistry. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1987; 170: S13–S32
   Web of Science ®Google Scholar
• Aromaa A, Björksten F, Eriksson A W., et al. Serum cholesterol and triglyceride concentrations of Finns and Finnish Lapps. Acta Med Scand 1975; 198: 13–22
   PubMedGoogle Scholar
• The Lipid Research Clinics Program Epidemiology committee. Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation 1979; 60: 427–39
   PubMed Web of Science ®Google Scholar
• Stein E A. Lipids, lipoproteins and apolipoproteins. Textbook of clinical chemistry, N W. Tietz. WB Saunders Company, Philadelphia 1986; 829–900
   Google Scholar
• Donahue R P., Jacobs D R., Jr, Sidney S, Wagen-knecht L E., Albers J J., Hulley S B. Distribution of lipoproteins and apoproteins in young adults. The CARDIA Study. Arteriosclerosis 1989; 9: 656–64
   PubMedGoogle Scholar
• Alvarez C, Orejas A, Gonzales S, Diaz R, Golomo L F. Reference intervals for serum lipids, lipoproteins and apolipoproteins in the elderly. Clin Chem 1984; 30: 404–6
   PubMed Web of Science ®Google Scholar
• Mattila K S., Marniemi J, Mäki J, Juva K. Lipids, lipoproteins and apolipoproteins in the elderly. Scand J Clin Lab Invest 1986; 46: 131–6
   PubMed Web of Science ®Google Scholar
• Kauppinen-Mäkelin R, Nikkilä E A. Serum lipoproteins in patients with myocardial infarction. Atherosclerosis 1988; 74: 65–74
   PubMed Web of Science ®Google Scholar
• Deckelbaum R J., Granot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984; 4: 225–31
   PubMedGoogle Scholar
• Patsch J R., Prasad S, Gotto A M., Jr, Bengtsson-Olivecrona G. Postprandial lipemia. A key for the conversion of high density lipoprotein-2 into high density lipoprotein-3 by hepatic lipase. J Clin Invest 1984; 74: 2017–23
   PubMed Web of Science ®Google Scholar
• Nieminen M S., Mattila K J., Aalto-Setälä K, et al. Lipoproteins and their genetic variation in subjects with and without angiographicaily verified coronary artery disease. Arteriosclerosis and Thrombosis 1992; 12: 58–69
   PubMedGoogle Scholar
• Patsch J R., Miesenböck G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arteriosclerosis and Thrombosis 1992; 12: 1336–45
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993; 269: 505–10
   PubMed Web of Science ®Google Scholar
• Berg B, Nilsson J-E, Solberg H E., Tryding N. Practical experience in the selection and preparation of reference individuals: empirical testing of the provisional Scandinavian recommendations. Reference values in laboratory medicine. The current state of the art, R Gräs-beck, T Alström. Wiley, Chichester 1981
   Google Scholar
• Lehtonen A, Marniemi J, Inberg M, Maatela J, Alanen E, Niittymaki K. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinester-ase activity and their discriminative values in patients with coronary by-pass operation. Atherosclerosis 1986; 59: 215–21
   PubMed Web of Science ®Google Scholar
• Frick H, Elo O, Haapa K, et al. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–45
   PubMed Web of Science ®Google Scholar